Last reviewed · How we verify
Tianshu capsule
Tianshu capsule is a Small molecule drug developed by Jiangsu Kanion Pharmaceutical Co., Ltd. It is currently FDA-approved for Adjunctive treatment in cancer patients, Cancer-related fatigue and immune support.
Tianshu capsule is a traditional Chinese medicine formulation that modulates immune function and promotes apoptosis in cancer cells through multiple herbal components.
The Tianshu capsule is a small molecule that acts as a neurokinin 1 receptor antagonist, classified as an antagonist. It has been studied in clinical trials for the treatment of migraine and chronic atrophic gastritis, with one trial specifically evaluating its safety and efficacy in treating migraine.
At a glance
| Generic name | Tianshu capsule |
|---|---|
| Sponsor | Jiangsu Kanion Pharmaceutical Co., Ltd |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
Mechanism of action
Tianshu is a polyherbal preparation used in Chinese medicine that combines multiple botanical extracts to enhance anti-tumor immunity and induce programmed cell death in malignant cells. The exact molecular targets remain incompletely characterized in Western pharmacological terms, though the formulation is believed to work through immunomodulation and direct cytotoxic effects. It is marketed primarily in China for cancer supportive care and adjunctive treatment.
Approved indications
- Adjunctive treatment in cancer patients
- Cancer-related fatigue and immune support
Common side effects
- Gastrointestinal upset
- Allergic reactions
Key clinical trials
- Evaluation of the Efficacy of Electroacupuncture in the Treatment of Chronic Atrophic Gastritis (NA)
- A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tianshu capsule CI brief — competitive landscape report
- Tianshu capsule updates RSS · CI watch RSS
- Jiangsu Kanion Pharmaceutical Co., Ltd portfolio CI
Frequently asked questions about Tianshu capsule
What is Tianshu capsule?
How does Tianshu capsule work?
What is Tianshu capsule used for?
Who makes Tianshu capsule?
What development phase is Tianshu capsule in?
What are the side effects of Tianshu capsule?
Related
- Manufacturer: Jiangsu Kanion Pharmaceutical Co., Ltd — full pipeline
- Therapeutic area: All drugs in Oncology
- Indication: Drugs for Adjunctive treatment in cancer patients
- Indication: Drugs for Cancer-related fatigue and immune support
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing